Clinical Trials Conditions Document 
The Cannigma
OCTOBER 11, 2021
The majority of people who use the cannabinoid cannabigerol (CBG) for medical reasons find it to be helpful or very helpful in treating a variety of health conditions, according to the findings of a recent survey. No clinical trial was used in the compilation of the study. who have used it to treat anxiety.
NORML
JANUARY 31, 2019
Proposed federal legislation to direct the agency to conduct clinical trials on the use of cannabis for PTSD and for other conditions is currently pending in the US House and Senate. Twenty percent of those surveyed acknowledged having previously used cannabis for medical purposes.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
NOVEMBER 17, 2020
Ohio is currently accepting petitions in an attempt to expand the list of qualifying conditions for medical cannabis. Medical cannabis is now available to residents in Ohio who meet one of 22 qualifying conditions laid out by House Bill 523. Strict Guidelines Must be Met Before Conditions Will Be Considered.
Cannabis Law Report
DECEMBER 2, 2021
(IGC) is excited to present preliminary positive secondary end point findings from its Phase 1 clinical trial for IGC-AD1. The results of the clinical trial have been submitted in the Clinical/Statistical Report (“CSR”) filed with the FDA, and relevant data is also available on Form 8-K filed with the SEC on December 2, 2021.
LifeCannMD
JANUARY 31, 2025
#image_title Families affected by Huntington’s Disease (HD) know to well that this hereditary neurodegenerative condition progressively impacts movement, cognition, and behavior, profoundly affecting both patients and their loved ones. The post Cannabis in Neurodegenerative Conditions: Hope for Huntingtons Disease?
FloridaMarijuana.net
OCTOBER 9, 2018
The use of cannabis has been well-documented throughout historical and ancient times and well supported through the medical literature. As with all medicinal interventions, strains may affect each person and medical condition differently. These descriptions are meant as a guide.
Veriheal
JULY 16, 2020
Despite the novelty of its drug policy findings, the document has gone largely unnoticed by reform advocates and the media. The panel, led by Jake Leinenkugel (a presidential nominee), asserted that psychedelics, such as MDMA and psilocybin, as well as cannabis, present promising ways to treat mental health conditions among military veterans.
Expert insights. Personalized for you.
132 
Let's personalize your content